T h e r a p e u t i c I n d e x 133 Composition Each mL of Liv.52 drops contains: Exts. Himsra (Capparis spinosa). .....................................17 mg Kasamarda (Cassia occidentalis)............................4 mg Kasani (Cichorium intybus).....................................17 mg Biranjasipha (Achillea millefolium)........................4 mg Kakamachi (Solanum nigrum)................................. 8 mg Jhavuka (Tamarix gallica). .......................................4 mg Arjuna (Terminalia arjuna). ...................................... 8 mg Processed in Bhringaraja (Eclipta alba), Bhumyaamalaki (Phyllanthus amarus), Punarnava (Boerhaavia diffusa), Guduchi (Tinospora cordifolia), Daruharidra (Berberis aristata), Mulaka (Raphanus sativus), Amalaki (Emblica officinalis), Chitraka (Plumbago zeylanica), Vidanga (Embelia ribes), Haritaki (Terminalia chebula), and Parpata (Fumaria officinalis). Each 5 mL of Liv.52 syrup contains: Exts. Himsra (Capparis spinosa). .....................................34 mg Kasamarda (Cassia occidentalis)............................8 mg Kasani (Cichorium intybus).....................................34 mg Biranjasipha (Achillea millefolium)........................8 mg Kakamachi (Solanum nigrum)...............................16 mg Jhavuka (Tamarix gallica). .......................................8 mg Arjuna (Terminalia arjuna). ....................................16 mg Processed in Bhringaraja (Eclipta alba), Bhumyaamalaki (Phyllanthus amarus), Punarnava (Boerhaavia diffusa), Guduchi (Tinospora cordifolia), Daruharidra (Berberis aristata), Mulaka (Raphanus sativus), Amalaki (Emblica officinalis), Chitraka (Plumbago zeylanica), Vidanga (Embelia ribes), Haritaki (Terminalia chebula), and Parpata (Fumaria officinalis). Liv.52® (drops, syrup, tablet, DS syrup, DS tablet) Unparalleled in liver care Liv.52 is a hepatospecific formulation, designed for the treatment and management of liver disorders. Liv.52 has a wide spectrum of therapeutic applications. Liv.52 restores the metabolic efficiency of the liver, minimizes damage to the hepatic parenchyma, and accelerates the rate of recovery in various liver disorders like infectious hepatitis, drug-induced hepatitis, non-alcoholic fatty liver disease (NAFLD)/metabolic dysfunction–associated fatty liver disease (MAFLD), and alcoholic liver disease (ALD). Liv.52 is a valuable adjuvant during prolonged illness. In anorexia, Liv.52 improves appetite, digestion, and assimilation. Liv.52 is one of the world’s most enduring hepatospecific formulations, accredited with more than 250 studies, and is available in a wide range of dosage forms to suit the requirement of patients of all age-groups. Liv.52 is safe for long-term use.
RkJQdWJsaXNoZXIy MjMwNjM2Nw==